Loading clinical trials...
Loading clinical trials...
Low-cost Detection of Dementia Using Electronic Health Records Data: Validation and Testing of the eRADAR Algorithm in a Pragmatic, Patient-centered Trial.
The eRADAR Brain Health Study seeks to refine and test a novel, low-cost strategy for increasing dementia detection within primary care.
eRADAR stands for "electronic health record (EHR) Risk of Alzheimer's and Dementia Assessment Rule." It is a low-cost tool or algorithm that uses readily available EHR data elements to identify high-risk patients. We will conduct a pragmatic randomized controlled trial to assess the impact of implementing eRADAR as part of a supported outreach process on dementia detection rates. We will also explore the impact of eRADAR implementation on healthcare utilization and patient experience.
Age
65 - No limit years
Sex
ALL
Healthy Volunteers
Yes
Kaiser Permanente Burien Medical Center
Burien, Washington, United States
Kaiser Permanente Kent Medical Center
Kent, Washington, United States
Kaiser Permanente Renton Medical Center
Renton, Washington, United States
Kaiser Permanente, Capitol Hill
Seattle, Washington, United States
Kaiser Permanente Northgate Medical Center
Seattle, Washington, United States
Start Date
June 29, 2022
Primary Completion Date
October 15, 2024
Completion Date
April 15, 2025
Last Updated
April 6, 2025
3,417
ACTUAL participants
Brain Health Assessment
OTHER
Lead Sponsor
Kaiser Permanente
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT04123314